期刊文献+

慢性HBV感染者各级肝脏纤维化不同部位VTQ测值比较研究 被引量:3

The difference of virtual touch quantification(VTQ) among different parts in the hepatic fibrosis of chronic HBV
下载PDF
导出
摘要 目的:进行慢性乙肝病毒(HBV)感染者各级肝脏纤维化不同部位声触诊量化技术(VTQ)测值的比较研究。方法:测定311例慢性肝病患者肝左叶、肝右前叶、肝右后叶VTQ值,慢性肝病患者均经肝穿刺活检,并行病理肝纤维化分级,以病理肝纤维化分级进行分组,分别对各组不同部位VTQ值进行对比研究。结果:311例中无S0级(因我院所有肝穿刺患者,肝功均有异常且病史较长,所以S0级极少见);S1级中,肝左叶与肝右前叶、肝右后叶差异有统计学意义(P<0.01),肝右前叶与肝右后叶差异无统计学意义(P=0.333);S2级中,肝左叶与肝右前叶、肝右后叶差异有统计学意义(P<0.01),肝右前叶与肝右后叶差异无统计学意义(P=0.505);S3级中,肝左叶、肝右前叶、肝右后叶两两间差异均无统计学意义(P>0.05);S4级中,肝左叶、肝右前叶、肝右后叶两两间差异均无统计学意义(P>0.05)。结论:测量肝左叶VTQ值时,因受心脏搏动、呼吸、腹主动脉搏动影响,测量值可信度差。因此,不宜用此部位VTQ测值估测肝纤维化程度。 Objective: To explore the difference of virtual touch quantification (VTQ) among dlflerent parts in the iaepatlc tlbro-sis of chronic HBV. Methods: A total of 311 patients with chronic liver disease receiving liver biopsy were enrolled in this stud- y, all patients liver tissue in the left lobe, the anterior and posterior of right lobe was checked by VTQ technique. The results were compared in different parts and the patients were grouped according to the degree of the hepatic fibrosis. Results: None of SO was included in 311 patients, for they had abnormal liver function and a long course. In S1 group, VTQ value was signifi-cantly different among the left lobe, the anterior and posterior of right lobe (P〈0.01). No significant difference showed be-tween the anterior and posterior of right lobe(P=0. 333). In $2 group, VTQ value was significantly different among the left lobe, the anterior and posterior of right lobe (P〈0.01). No significant difference showed between the anterior and posterior of right lobe (P=0. 505). In S3 group, no significant difference showed among the left lobe, the anterior and posterior of right lobe(P〉0.05). In S4 group, no significant difference showed among the left lobe, the anterior and posterior of right lobe(P〉 0.05). Conclusion:The credibility of the VTQ value in left lobe is poor, for heart beat, breathing, abdominal aorta pulse could produce an effect on the act of measuring. In a word, it is not scientific to measure VTQ value in the left lobe of the liver.
出处 《中国中西医结合影像学杂志》 2012年第4期292-294,共3页 Chinese Imaging Journal of Integrated Traditional and Western Medicine
基金 厦门市科技局资助项目(编号:3502Z20104012)
关键词 肝炎病毒 乙型 肝硬化 超声检查 nepatitis virus,B liver cirrhosis ultrasonography
  • 相关文献

参考文献11

  • 1中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14007
  • 2Lonis I?A, Friedman SL. Kaplan MM. Is liver fibrosis reversible[J]. N Engl J Med.2001,344 : 152-154.
  • 3孙德胜,孟繁坤,王金锐,邵金华,崔立刚.慢性肝病肝剪切波速与纤维化分级的相关性研究[J].中国医学影像学杂志,2009,17(4):241-245. 被引量:69
  • 4Edossa P, Daegere D, Paradis V. Sampling variahility of liver fibrosis in chronic hepatitis C[J]. Hepatology, 2003,38:149.
  • 5Regev A. Berho M.Jeffer LJ.et al. Samping eror and intraobserver vairation in liver biopsy in patients with chronic HCV infection[J]. Am J Gastorenterol. 2002,97 : 2614.
  • 6Sktdkue I. EI-Naga HA, Madda JP. et al, Samping vairability on percutaneous Jiver biopsy in patients with chronic bepas C virus Jniection[J]. Stand J Casteroent erol, 2003.38:427.
  • 7Monica l,upsor, Radu Ladet. Horia Stefanescu,et aI. Analysis of histopathological changes that influence liver stiffness in chronic hepatitis C. Results from a cohort of 324, patients[J]. J Gastrointestin Liver Dis.2008,17:155.
  • 8Ratziu V,Charlotte F, Heurtier A,el al. Sampling varibaility of liver biopsy in nonlacoholic fatty liver disease[J].Gastroenteroloyg, 2005, 128:1898.
  • 9彭虹,罗新华,张世萍,刘天昭.Fibroscan检测慢性HBV感染者肝纤维化的临床意义[J].第三军医大学学报,2011,33(14):1546-1547. 被引量:7
  • 10张丽涓,王志毅,张大志,石小枫,胡鹏,周智,刘杞,任红.瞬时弹性波扫描仪检查在慢性乙型肝炎肝纤维化患者中的应用[J].重庆医科大学学报,2011,36(6):721-724. 被引量:17

二级参考文献26

  • 1Ioan Sporea,Roxana Sirli,Alexandra Deleanu,Adriana Tudora,Alina Popescu,Manuela Curescu,Simona Bota.Liver stiffness measurements in patients with HBV vs HCV chronic hepatitis:A comparative study[J].World Journal of Gastroenterology,2010,16(38):4832-4837. 被引量:19
  • 2杨志芳,毛飞,黄正明.肝纤维化的形成机制及治疗的研究进展[J].解放军药学学报,2006,22(2):129-132. 被引量:13
  • 3Hanni,Yeshua,Ran Oren.Non invasive assessment of liver fibrosis.Ann Transplant,2008,13(2):5
  • 4Ziol M,Handra-Luca A,Kettaneh A,et al.Noninvasive Assessment of Liver Fibrosis by Measurement of Stiffness in Patients With Chronic Hepatitis C.Hepatology,2005,41(1):48
  • 5Friedman SL,Bansal MB.Reversal ofhepatic fibrosis-fact or fantasy? Hepatology,2006,43(2 Suppl.1):S82
  • 6Don C,Rockey.Noninvasive Assessment of Liver Fibrosis and Portal Hypertension With Transient Elastography.Gastroenterology,2008,134(1):8
  • 7Jules L,John G.American Gastroenterological Association technical review on the management of hepatitis C.Gastroenterology,2006,130(1):231
  • 8Mayo M,Parks J,Huet B,et al.Serum fibrosis markers predict future clinical decompensation in primary biliary cirrhosis better than liver biopsy,bilirubin,or Mayo risk score.Hepatology,2006,44(suppl.1):630
  • 9Edossa P,Daegere D,Paradis V.Sampling variability of liver fibrosis in chronic hepatitis C.Hepatology,2003,38(6):1449
  • 10Regev A,Berho M,Jeffer LJ,et al.Samping error and intraobserver variation in liver biopsy in patients with chronic HCV infection.Am J Gastroenterol,2002,97(10):2614

共引文献14118

同被引文献18

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部